Effectiveness of Endoscopic Screening on Esophageal Cancer Incidence and Mortality: A 9-Year Report of the Endoscopic Screening for Esophageal Cancer in China (ESECC) Randomized Trial

View Full Paper

Ask AI

Bookmark

Endoscopic screening significantly reduces the incidence and mortality of esophageal cancer.
The trial showed that 9 years of screening resulted in markedly lower rates of diagnosis and death from esophageal squamous cell carcinoma.
Analyzed outcomes from a randomized trial assessing screening against esophageal cancer over a substantial timeframe of 9 years in China, with notable implications for public health strategies in cancer prevention and treatment efficiency. Supports wider implementation to potentially lower cancer-related deaths.

Implication

Randomized trial evaluates endoscopic screening's effectiveness on esophageal cancer outcomes, suggesting significant benefits.

To evaluate the effectiveness of endoscopic screening against incidence of and mortality from esophageal squamous cell carcinoma (ESCC).

No takes yet. Share an insight, caveat, or question.

Liu et al. (2024) studied this question.

View Full Paper

Ask AI

Bookmark

Randomized trial evaluates endoscopic screening's effectiveness on esophageal cancer outcomes, suggesting significant benefits.

To evaluate the effectiveness of endoscopic screening against incidence of and mortality from esophageal squamous cell carcinoma (ESCC).